Author: Fiona Craig

Next plc (LSE:NXT) has published its Half Year Report for the period ending July 2025, alongside the declaration of an interim ordinary dividend of 87 pence per share. The dividend is scheduled for payment on 5 January 2026, with an ex-dividend date of 4 December 2025. The announcement reinforces the company’s commitment to delivering shareholder value and may positively influence investor sentiment.

Next’s performance continues to be underpinned by consistent revenue growth and strong profit margins, driving its favorable stock profile. Technical indicators show a bearish trend, while valuation metrics suggest the shares are fairly priced. The absence of recent earnings calls or corporate events does not materially affect the outlook.

About Next plc

Next plc is a leading retailer specializing in clothing, footwear, and home products. The company offers an extensive range of fashion and lifestyle items, serving a broad customer base through both physical stores and online channels.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

ValiRx plc (LSE:VAL) announced that its subsidiary, Inaphaea Limited, has partnered with TwinEdge Bioscience to accelerate cancer drug development using digital ‘patient avatars’ powered by AI and computational biology. This collaboration seeks to create one of the largest populations of digital twins, aiming to reduce clinical trial costs and improve patient-drug matching.

Inaphaea is also enhancing its capabilities through agreements for new cancer cell models and the 3K Screen program, which has already identified promising drug candidates for further testing and potential commercialization.

While the company continues to make strategic scientific progress, financial performance remains challenging, with significant losses and dependence on external funding. Technical indicators show a neutral to slightly positive outlook, but the overall valuation is impacted by unprofitability.

About ValiRx

ValiRx plc is a life sciences company focused on early-stage cancer therapeutics and women’s health. The firm aims to translate innovative scientific research into effective medicines, providing a framework to accelerate clinical development and improve patient outcomes.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Iofina plc (LSE:IOF) has achieved record revenue and iodine output for the first half of 2025, with revenue rising 12.3% to $29.2 million and gross profit increasing 21.2% to $6.3 million. Iodine production grew by 10.6%, driven by strong market demand and favorable pricing. The commissioning of the new IO#11 plant is expected to further boost output, with anticipated production of 400–440 metric tonnes of crystalline iodine in the second half of the year.

The company remains well-positioned for continued growth, leveraging robust cash generation and available banking facilities to support ongoing operational investments.

About Iofina

Iofina plc is a vertically integrated producer of iodine and specialty chemical products, and the second-largest iodine producer in North America. Operating through its subsidiaries Iofina Resources and Iofina Chemical, the company extracts iodine from oil and gas brine streams using environmentally friendly processes and operates eight iodine extraction plants in Oklahoma.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Journeo plc (LSE:JNEO) has received a £1.5 million order from a Northern Transport Partnership to supply and install high-definition TFT and ultra-low power ePaper displays, enhancing real-time passenger information systems. This contract represents a key step in expanding Journeo’s transport display technology offerings and reinforces its position in delivering sustainable solutions for the UK public transport sector, supporting the authority’s Carbon Net Zero goals.

Journeo’s financial performance remains strong, driven by solid revenue growth and operational stability. Technical indicators present a mixed outlook, while valuation appears reasonable. The lack of recent earnings calls or corporate events does not materially affect the company’s outlook.

About Journeo

Journeo plc is a leading provider of intelligent solutions for transport networks and critical national infrastructure. The company delivers sustainable technologies for public transport and infrastructure protection, including CCTV, telematics, real-time communications, and electronic passenger information systems. Operating through six subsidiaries—including Journeo Fleet Systems, Journeo Passenger Systems, Infotec, Crime and Fire Defence Systems, Journeo AS, and Journeo AB—Journeo serves markets in the UK, Denmark, Sweden, and Iceland.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

SRT Marine Systems plc (LSE:SRT) has secured a major contract valued at approximately $200 million from a sovereign client to provide a maritime surveillance system, pending finalization. The award is set to strengthen SRT’s contract portfolio and underscores the company’s growing presence and competitive position in the maritime domain awareness sector.

Despite this business momentum and promising strategic projects, the company faces significant financial challenges. While technical indicators suggest strong market interest, uncertainties around financial stability and valuation remain key considerations.

About SRT Marine Systems

SRT Marine Systems PLC is a global provider of maritime intelligence and surveillance solutions, supporting civil defense, navigation safety, and operational efficiency. Its systems allow agencies, including Coast Guards and Fishery Authorities, to conduct intelligence-driven operations for maritime security. The company serves government bodies as well as commercial and leisure vessel operators worldwide.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Pantheon Resources plc (LSE:PANR) has announced that hydraulic fracture stimulation and well testing are scheduled for its Dubhe-1 well on Alaska’s North Slope, a key step in developing the Ahpun reservoir. The work, managed by Element Technical Services Inc, is expected to improve operational insights and provide critical data to guide future development, potentially strengthening Pantheon’s strategic position in the oil and gas sector.

While the company faces operational and financial challenges, including negative profitability and cash flow constraints, ongoing strategic initiatives and positive corporate developments offer potential upside.

About Pantheon Resources

Pantheon Resources plc is an AIM-listed oil and gas company focused on the development of its wholly owned Ahpun and Kodiak fields on Alaska’s North Slope. The company holds independently certified contingent recoverable resources estimated at approximately 1.6 billion barrels of ANS crude and 6.6 Tcf of associated natural gas. Pantheon aims to demonstrate the sustainable value of its resources by 2028, leveraging proximity to existing infrastructure for operational advantage.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Tekcapital plc (LSE:TEK) has announced that its portfolio company, Guident Corp., has submitted a registration statement to the U.S. Securities and Exchange Commission in preparation for a proposed initial public offering on the NASDAQ under the ticker GDNT. Details regarding the number of shares and pricing range have not yet been disclosed. Tekcapital currently owns a 70% stake in Guident, and the IPO could have a meaningful effect on its financial position and market influence.

About Tekcapital

Tekcapital plc is a UK-based intellectual property investment group that focuses on commercializing university-developed technologies to create valuable products that improve quality of life. The company is listed on the AIM market of the London Stock Exchange.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Duke Capital Limited (LSE:DUKE) has declared an interim dividend of 0.70 pence per share for the second quarter of its financial year. The ex-dividend date is 25 September 2025, with the record date on 26 September and payment scheduled for 14 October 2025. The dividend reflects the company’s ongoing commitment to delivering consistent returns to shareholders and reinforcing its position in the hybrid capital solutions market.

While Duke Capital continues to face challenges in revenue and overall profitability, its stable dividend policy offers investors an attractive yield. Technical indicators show mixed signals with a slight bearish trend, and current valuation levels are high, though the dividend partially offsets this concern.

About Duke Capital

Duke Capital Limited is a specialist provider of hybrid capital solutions for SMEs in Europe and North America. The firm combines elements of equity and debt to provide long-term financing that avoids refinancing risk and short-term exit pressures. Duke Capital operates under three main investment principles: capital preservation, attractive dividend returns, and potential upside upon exit. The company is listed on AIM under the ticker DUKE and is headquartered in Guernsey.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Petrel Resources plc (LSE:PET) has released its unaudited financial results for the first half of 2025, recording a loss of €357,000. Despite the financial setback, the company remains optimistic about future opportunities, driven by renewed global demand for reliable energy fuels and critical minerals.

Petrel is actively pursuing acquisitions and growth initiatives across various energy sectors, supported by potential offtake agreements with partners in the EU, China, and India. The company also expects to benefit from favorable fiscal terms and increasing market support for junior exploration firms.

About Petrel Resources

Petrel Resources plc is a junior hydrocarbon exploration company with core interests in Iraq and Ghana. The firm focuses on securing high-potential exploration acreage in the Middle East and other underexplored regions, aiming to realize value through strategic partnerships or farm-out agreements with major energy players.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Judges Scientific plc (LSE:JDG) has reported its interim results for the first half of 2025, posting a 15% rise in revenue to £70.2 million and a 17% increase in adjusted pre-tax profit to £12.6 million. The performance comes despite a difficult trading backdrop marked by reduced U.S. federal research funding and challenges within some divisions.

The group benefited from robust contributions by Geotek and a recovery in the China and Hong Kong markets. In line with its progress, Judges lifted its interim dividend by 10%. Management remains focused on tackling trading challenges, driving organic growth, and leveraging its strong order book and financial position.

While the company’s results reflect resilience and strong execution, technical signals point to a cautious outlook. A relatively high P/E ratio and bearish indicators suggest that valuation pressures could weigh on the stock, even as corporate developments highlight confidence in long-term growth.

About Judges Scientific

Judges Scientific plc is a specialist group that acquires and develops businesses in the scientific instrumentation sector. The company now comprises 25 mainly UK-based businesses, with products sold worldwide to universities, research facilities, manufacturers, and regulatory bodies. Operating in niche markets with solid long-term fundamentals, Judges pursues a strategy of selective acquisitions, organic growth, and steady dividend generation to build sustainable profitability and cash flow.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.